K
Kensuke Nakajima
Researcher at Japanese Ministry of Health, Labour and Welfare
Publications - 3
Citations - 608
Kensuke Nakajima is an academic researcher from Japanese Ministry of Health, Labour and Welfare. The author has contributed to research in topics: Disease & Medicine. The author has an hindex of 1, co-authored 1 publications receiving 547 citations.
Papers
More filters
Journal ArticleDOI
Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled Analysis
Maria D. Van Kerkhove,Katelijn Vandemaele,Vivek Shinde,Giovanna Jaramillo-Gutierrez,Artemis Koukounari,Christl A. Donnelly,Luis O. Carlino,Rhonda Owen,Beverly Paterson,Louise Pelletier,Julie Vachon,Claudia González,Yu Hongjie,Feng Zijian,Shuk Kwan Chuang,Albert Ka-Wing Au,Silke Buda,Gérard Krause,Walter Haas,Isabelle Bonmarin,Kiyosu Taniguichi,Kensuke Nakajima,Tokuaki Shobayashi,Yoshihiro Takayama,Tomi Sunagawa,Jean-Michel Heraud,Arnaud Orelle,Ethel Palacios,Marianne A B van der Sande,C. C. H. Lieke Wielders,Darren Hunt,Jeffrey Cutter,Vernon J. Lee,Vernon J. Lee,Juno Thomas,Patricia Santa-Olalla,Maria J. Sierra-Moros,Wanna Hanshaoworakul,Kumnuan Ungchusak,Richard Pebody,Seema Jain,Anthony W. Mounts +41 more
TL;DR: This study analyzes data from 19 countries, comprising some 70,000 hospitalized patients with severe H1N1 infection, to reveal risk factors for severe pandemic influenza, which include chronic illness, cardiac disease, chronic respiratory disease, and diabetes.
Journal ArticleDOI
Adverse Events Following COVID-19 Vaccination in Young Japanese People: A Case-Control Study of the Risk of Systemic Adverse Events by A Questionnaire Survey
Marie Suehiro,Shinya Okubo,Kensuke Nakajima,Kosuke Kanda,Masanobu Hayakawa,Shigeru Oiso,Tsutomu Kabashima,Hideaki Fujita,Yukio Ando,Takahiro Muro +9 more
TL;DR: The results of this study showed that female participants had a higher incidence of adverse events and the ratio of naive B cells and activated CD8-positive T cells detected as immunological features that positively correlate with the increase in antibody titre after vaccination.
Journal ArticleDOI
Development of a novel positive pressure protective suit for Biosafety Level 4 laboratory in Japan.
Shintaro Shichinohe,Yasuteru Sakurai,K. Hayasaka,Eri Yamada,Katsuaki Shinohara,Yohei Kurosaki,Kensuke Nakajima +6 more
TL;DR: In 2019, the first Japanese suit-type BSL-4 laboratory was constructed at Nagasaki University as mentioned in this paper , where a positive pressure protection suit (PPPS) was designed to protect and isolate laboratory workers from pathogens and the laboratory environment.